Frayde-Gómez, H., Chimal-Vega, B., Pulido-Capiz, A., Muñoz-Ayala, A., Galindo-Hernández, O., Vique-Sanchez, J. L., Leija-Montoya, A. G., Díaz-Molina, R., Madero-Ayala, P. A., Ramos-Ibarra, M. A., García-González, V. (2026). The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model. Scientific Reports. https://doi.org/10.1038/s41598-025-31313-6